<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://napwa.org.au" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>tenofovir</title>
 <link>http://napwa.org.au/articles-by-tx/57</link>
 <description>Embedded view for the TXinfo ctype</description>
 <language>en-au</language>
<item>
 <title>AIDS 2010: microbicide breakthrough</title>
 <link>http://napwa.org.au/2010/07/21/aids-2010-microbicide-breakthrough</link>
 <description> &lt;p&gt;In what is being called a major breakthrough, a trial of a vaginal microbicide gel in South African women has shown for the first time that such a product can be effective against HIV infection.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/2010/07/21/aids-2010-microbicide-breakthrough&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/taxonomy/term/346">conference reports</category>
 <category domain="http://napwa.org.au/defeating-hiv/hiv-prevention">HIV prevention</category>
 <category domain="http://napwa.org.au/defeating-hiv/the-global-hiv-epidemic/international-aids-conference">International AIDS Conference</category>
 <category domain="http://napwa.org.au/living-with-hiv/sex-and-relationships/microbicides">microbicides</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <enclosure url="http://napwa.org.au/image/view/2330/preview" length="30999" type="image/jpeg" />
 <pubDate>Wed, 21 Jul 2010 00:42:16 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">2331 at http://napwa.org.au</guid>
</item>
<item>
 <title>Antiretrovirals and your kidneys</title>
 <link>http://napwa.org.au/pl/2009/12/antiretrovirals-and-your-kidneys</link>
 <description> &lt;p&gt;Despite having been linked to the kidneys, tenofovir (Viread and also in the combination pill Truvada) appears not to cause more problems than other &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/104&quot;&gt;&lt;span&gt;NRTI&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A type of anti-HIV drug that works by inhibiting a stage of the HIV life cycle called reverse transcription.  Non-nucleosides work in a similar way, but are chemically different.&lt;/span&gt; drugs, US investigators have reported.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2009/12/antiretrovirals-and-your-kidneys&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/taxonomy/term/265">news</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors">protease inhibitors</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <category domain="http://napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/treatment-side-effects">treatment side effects</category>
 <enclosure url="http://napwa.org.au/image/view/2036/preview" length="21325" type="image/jpeg" />
 <pubDate>Wed, 25 Nov 2009 21:52:21 -0800</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">1985 at http://napwa.org.au</guid>
</item>
<item>
 <title>Bone health and HIV</title>
 <link>http://napwa.org.au/pl/2009/06/bone-health-and-hiv</link>
 <description> &lt;p&gt;Those of us with HIV are more likely to have conditions such as osteopenia (low bone mineral density) and osteoporosis (weakened bones) than our negative contemporaries.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2009/06/bone-health-and-hiv&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/bone-disorders">bone disorders</category>
 <category domain="http://napwa.org.au/defeating-hiv/hiv-research/clinical-research">clinical research</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <enclosure url="http://napwa.org.au/image/view/1585/preview" length="39919" type="image/jpeg" />
 <pubDate>Thu, 04 Jun 2009 23:13:43 -0700</pubDate>
 <dc:creator>Jill Sergeant</dc:creator>
 <guid isPermaLink="false">1586 at http://napwa.org.au</guid>
</item>
<item>
 <title>FTC approved, ddC to be withdrawn</title>
 <link>http://napwa.org.au/pl/2005/04/ftc-approved-ddc-to-be-withdrawn</link>
 <description> &lt;p&gt;A new &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/122&quot;&gt;&lt;span&gt;antiretroviral&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A medication or other substance which is active against retroviruses such as HIV.&lt;/span&gt; medication, FTC (emtricitabine, Emtriva) was listed on the &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/121&quot;&gt;&lt;span&gt;PBS&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.&lt;/span&gt; and became available for S100 prescription from 1 April.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2005/04/ftc-approved-ddc-to-be-withdrawn&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/ftc">emtricitabine (FTC)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/saquinavir">saquinavir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/ddc">zalcitabine (ddC)</category>
 <enclosure url="http://napwa.org.au/image/view/1239/preview" length="9856" type="image/jpeg" />
 <pubDate>Wed, 18 May 2005 07:07:19 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">143 at http://napwa.org.au</guid>
</item>
<item>
 <title>Cambodian PREP trial halted</title>
 <link>http://napwa.org.au/pl/2004/08/cambodian-prep-trial-halted</link>
 <description> &lt;p&gt;A controversial Cambodian trial of tenofovir for pre-exposure prophylaxis (PREP) is unlikely to proceed after sex workers and the Cambodian government claimed the trial did not include adequate safeguards for the health and human rights of the participants.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2004/08/cambodian-prep-trial-halted&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/defeating-hiv/the-global-hiv-epidemic/hiv-in-our-region">HIV in our region</category>
 <category domain="http://napwa.org.au/living-with-hiv/defeating-hiv/sex-and-relationships/hiv-prevention/pre-exposure-prophylaxis-prep">Pre-exposure prophylaxis (PrEP)</category>
 <category domain="http://napwa.org.au/living-with-hiv/sex-work">sex work</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <pubDate>Sat, 14 Aug 2004 15:00:38 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">81 at http://napwa.org.au</guid>
</item>
<item>
 <title> Pre-exposure prophylaxis study for Cambodia</title>
 <link>http://napwa.org.au/pl/2003/12/pre-exposure-prophylaxis-study-for-cambodia</link>
 <description> &lt;p&gt;Australian researchers have teamed up with the US and Cambodia to conduct a study of the potential of the &lt;span class=&quot;caps&quot;&gt;HIV&lt;/span&gt; &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/123&quot;&gt;&lt;span&gt;antiviral&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A medication or substance which is active against one or more viruses. May include anti-HIV drugs, but these are more accurately termed antiretrovirals.&lt;/span&gt; tenofovir, taken daily, to prevent &lt;span class=&quot;caps&quot;&gt;HIV&lt;/span&gt; infection in women at high risk.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2003/12/pre-exposure-prophylaxis-study-for-cambodia&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://napwa.org.au/defeating-hiv/the-global-hiv-epidemic/hiv-in-our-region">HIV in our region</category>
 <category domain="http://napwa.org.au/living-with-hiv/defeating-hiv/sex-and-relationships/hiv-prevention/pre-exposure-prophylaxis-prep">Pre-exposure prophylaxis (PrEP)</category>
 <category domain="http://napwa.org.au/living-with-hiv/sex-work">sex work</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <pubDate>Sun, 14 Dec 2003 14:00:36 -0800</pubDate>
 <dc:creator />
 <guid isPermaLink="false">125 at http://napwa.org.au</guid>
</item>
<item>
 <title>The power of one</title>
 <link>http://napwa.org.au/pl/2003/12/the-power-of-one</link>
 <description> &lt;p&gt;We all want simpler treatment regimens with fewer side effects and no meal restrictions, right? Well how does once-a-day treatment sound? As &lt;span class=&quot;caps&quot;&gt;PAUL&lt;/span&gt; &lt;span class=&quot;caps&quot;&gt;KIDD&lt;/span&gt; reports, it may be closer than you think.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2003/12/the-power-of-one&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/ddi">didanosine (ddI)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nnrtis/efavirenz">efavirenz</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/ftc">emtricitabine (FTC)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/fosamprenavir">fosamprenavir/amprenavir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/3tc">lamivudine (3TC)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nnrtis/nevirapine">nevirapine</category>
 <category domain="http://napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/entry-inhibitors/pr">PRO-542</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/ritonavir">ritonavir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/saquinavir">saquinavir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/d4t">stavudine (d4T)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/azt">zidovudine (AZT)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/multi-class-formulations">multi-class formulations</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/experimental-treatments">experimental treatments</category>
 <enclosure url="http://napwa.org.au/image/view/1263/preview" length="9870" type="image/jpeg" />
 <pubDate>Sun, 14 Dec 2003 12:00:21 -0800</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">132 at http://napwa.org.au</guid>
</item>
<item>
 <title>&#039;The greatest health crisis in human history&#039;</title>
 <link>http://napwa.org.au/pl/2003/08/the-greatest-health-crisis-in-human-history</link>
 <description> &lt;p&gt;The major international &lt;span class=&quot;caps&quot;&gt;AIDS&lt;/span&gt; conference for 2003 has ended with encouraging signs of growing international commitment to fight &lt;span class=&quot;caps&quot;&gt;AIDS&lt;/span&gt; in the developing world, and with several promising medical developments.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2003/08/the-greatest-health-crisis-in-human-history&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/diarrhoea">diarrhoea</category>
 <category domain="http://napwa.org.au/understanding-hiv-treatments/treating-hiv/salvage-therapy/understanding-hiv-treatments/drug-resista">drug resistance</category>
 <category domain="http://napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/heart-disease">heart disease</category>
 <category domain="http://napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/hepatitis-c">hepatitis C</category>
 <category domain="http://napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors">protease inhibitors</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <category domain="http://napwa.org.au/defeating-hiv/the-global-hiv-epidemic">The global HIV epidemic</category>
 <category domain="http://napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments">tipranavir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/treatment-interruption">treatment interruption</category>
 <enclosure url="http://napwa.org.au/image/view/1278/preview" length="32268" type="image/jpeg" />
 <pubDate>Thu, 31 Jul 2003 07:00:22 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">310 at http://napwa.org.au</guid>
</item>
<item>
 <title>Retro roundup</title>
 <link>http://napwa.org.au/pl/2003/04/retro-roundup</link>
 <description> &lt;p&gt;The 10th Conference on Retroviruses and Opportunistic Infections took place in Boston in February. This annual conference is a very highly regarded event with a strong scientific focus, so it often produces a number of important advances in our understanding of &lt;span class=&quot;caps&quot;&gt;HIV&lt;/span&gt; and its treatment, and this year was no exception.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2003/04/retro-roundup&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nnrtis/efavirenz">efavirenz</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors/t-20">enfuvirtide (T-20)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nnrtis/nevirapine">nevirapine</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <enclosure url="http://napwa.org.au/image/view/1274/preview" length="21826" type="image/jpeg" />
 <pubDate>Mon, 31 Mar 2003 14:00:13 -0800</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">264 at http://napwa.org.au</guid>
</item>
<item>
 <title>News and treatments briefs</title>
 <link>http://napwa.org.au/pl/2003/02/news-and-treatments-briefs</link>
 <description> &lt;p&gt;Selected brief news items from the pages of &lt;em&gt;Positive Living&lt;/em&gt;.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://napwa.org.au/pl/2003/02/news-and-treatments-briefs&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/nrtis/ftc">emtricitabine (FTC)</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/immune-based-therapies/il-2">IL-2</category>
 <category domain="http://napwa.org.au/living-with-hiv/positive-women">Positive women</category>
 <category domain="http://napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <category domain="http://napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/thrush">thrush</category>
 <pubDate>Fri, 31 Jan 2003 06:00:20 -0800</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">215 at http://napwa.org.au</guid>
</item>
</channel>
</rss>
